The Effects of Chicken Extract on Mental Energy in Healthy Adults and the Underlying Mechanisms

NCT ID: NCT06021223

Last Updated: 2025-09-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

189 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-08-22

Study Completion Date

2025-01-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This exploratory trial investigates the effect of a chicken extract supplement on mental energy and its potential underlying mechanisms of action among healthy adults using a randomized, double-blind, placebo-controlled clinical trial design. Mental energy is a multi-dimensional construct comprising transient feelings about fatigue, vigor and motivation and cognitive performance in terms of sustained attention and reaction time.

A sub-study investigates the immediate biochemical changes after taking chicken extract.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Adults

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chicken extract supplement (high-dose)

140ml of chicken extract supplement (high-dose) to be consumed daily for 2 weeks

Group Type EXPERIMENTAL

Chicken extract supplement (high-dose)

Intervention Type DIETARY_SUPPLEMENT

140ml of chicken extract supplement (high-dose) to be consumed daily for 2 weeks

Chicken extract supplement (low-dose)

140ml of chicken extract supplement (low-dose) to be consumed daily for 2 weeks

Group Type EXPERIMENTAL

Chicken extract supplement (low-dose)

Intervention Type DIETARY_SUPPLEMENT

140ml of chicken extract supplement (low-dose) to be consumed daily for 2 weeks

Placebo

140ml of placebo (caesinate) to be consumed daily for 2 weeks

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

140ml of placebo to be consumed daily for 2 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chicken extract supplement (high-dose)

140ml of chicken extract supplement (high-dose) to be consumed daily for 2 weeks

Intervention Type DIETARY_SUPPLEMENT

Chicken extract supplement (low-dose)

140ml of chicken extract supplement (low-dose) to be consumed daily for 2 weeks

Intervention Type DIETARY_SUPPLEMENT

Placebo

140ml of placebo to be consumed daily for 2 weeks

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female at 35-64 years of age
* Assessed by investigator to be in good health
* Normal cognition based on investigator's clinical judgement per the routine practice
* Modified PSQI score \> 5
* Agree to participate in the study and provide written informed consent
* Agree to abstain from herbal extracts or dietary supplements throughout the study period

Exclusion Criteria

* BMI \< 18.5 or ≥ 27 kg/m2
* Concurrent pharmacological treatments
* Current systemic diseases or current/history of neurological or cerebrovascular diseases
* Active peptic ulcer, or a history of peptic ulcer within the last 2 years
* Medications or interventions in the last 4 weeks, which in the investigators' judgement could potentially affect the outcome measures
* Regular significant quantities of dietary supplements or herbal extracts (\> 2 times a week) in the last 4 weeks
* Regular excessive caffeine consumption, heavy alcohol consumption or heavy habitual smokers
* Any drastic changes in lifestyle (including diet, smoking, sleep, exercise, and mental and physical activities) in the last 4 weeks
* Not able to maintain the same lifestyle throughout the study period
* Inadequate visual and auditory acuity to allow neuropsychological testing per investigator's judgment
* Inability to undergo fMRI scan
* Any consumption of chicken extract supplement, or carnosine or anserine supplement, in the preceding 4 weeks
* History of allergy to caseinate, milk, or chicken meat
* Women who are pregnant or lactating or intending to do so
* Current enrolment in another interventional study
* Subjects who show unstable sleep habits during the previous month
* Excessive blood donation or blood drawn prior to baseline
Minimum Eligible Age

35 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Taipei Medical University Shuang Ho Hospital

OTHER

Sponsor Role collaborator

Brand's Suntory Asia

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Taipei Medical University Hospital Shuang Ho Hospital

New Taipei City, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BEC-002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Effect of Lemongrass on Aerobic Performance
NCT07195240 NOT_YET_RECRUITING NA
Mushroom Blend on Oxygen Kinetics
NCT02075892 COMPLETED NA